Understanding the Roles of the Hedgehog Signaling Pathway during T-Cell Lymphopoiesis and in T-Cell Acute Lymphoblastic Leukemia (T-ALL)

Int J Mol Sci. 2023 Feb 3;24(3):2962. doi: 10.3390/ijms24032962.

Abstract

The Hedgehog (HH) signaling network is one of the main regulators of invertebrate and vertebrate embryonic development. Along with other networks, such as NOTCH and WNT, HH signaling specifies both the early patterning and the polarity events as well as the subsequent organ formation via the temporal and spatial regulation of cell proliferation and differentiation. However, aberrant activation of HH signaling has been identified in a broad range of malignant disorders, where it positively influences proliferation, survival, and therapeutic resistance of neoplastic cells. Inhibitors targeting the HH pathway have been tested in preclinical cancer models. The HH pathway is also overactive in other blood malignancies, including T-cell acute lymphoblastic leukemia (T-ALL). This review is intended to summarize our knowledge of the biological roles and pathophysiology of the HH pathway during normal T-cell lymphopoiesis and in T-ALL. In addition, we will discuss potential therapeutic strategies that might expand the clinical usefulness of drugs targeting the HH pathway in T-ALL.

Keywords: Hedgehog signaling; T-ALL; crosstalk; signaling pathways; targeted therapy; thymocyte differentiation.

Publication types

  • Review

MeSH terms

  • Hedgehog Proteins* / metabolism
  • Humans
  • Lymphopoiesis
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*
  • Signal Transduction / physiology
  • T-Lymphocytes / metabolism

Substances

  • Hedgehog Proteins

Grants and funding